(Q36962748)

English

Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.

scientific article published on 20 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

based on heuristic

inferred from title

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

Bradford D Gessner

3

object named as

Bradford D Gessner

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

author name string

Sabine Arnoux

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Clement Weinberger

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

0 references

publication date

20 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

7720-7731

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

The effectiveness of vaccination against influenza in healthy, working adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Heterogeneity of case definitions used in vaccine effectiveness studies--and its impact on meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Heterogeneity of influenza case definitions and implications for interpreting and comparing study results

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Effectiveness and economical impact of vaccination against influenza among a working population in Moscow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Assessment of effectiveness of Vaxigrip

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Influenza vaccine in healthy children: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Reduction of acute respiratory illness (ARI) due to a voluntary workplace influenza vaccination program: who are more likely to get the benefit?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

A case-control study of influenza vaccine effectiveness among Malaysian pilgrims attending the Haj in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Immune response to influenza vaccination in community-dwelling Chinese elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Safety and immunogenicity of a paediatric presentation of an influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Comparison of three different influenza vaccines in institutionalised elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Response to influenza vaccine in people with non-protective HI antibody titers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Economic analysis of influenza vaccination and antiviral treatment for healthy working adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Effectiveness of school-based influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

The role of cell culture vaccines in the control of the next influenza pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.063

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.08.063

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36962748&oldid=1531263851"